By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GenKyoTex S.A.  

16, Chemin des Aulx
CH-1228, Plan-Les-Ouates
  Geneva    Switzerland
Phone: 41-0-22-880-10-25 Fax: 41-0-22-880-10-13


SEARCH JOBS








Company News
GenKyoTex S.A. Completes Enrollment Into Phase 2 Trial Of NOX1&4 Inhibitor GKT137831 In Diabetic Nephropathy 11/13/2014 10:56:51 AM
GenKyoTex S.A. Announces New Senior Management And Board Appointments 5/19/2014 6:47:44 AM
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis 4/10/2014 9:22:56 AM
GenKyoTex S.A. NOX Inhibitor GKT137831 Successfully Shown To Halt Diabetic Kidney Disease 11/11/2013 9:06:20 AM
GenKyoTex S.A. Collaborators Elucidate Role of NOX4 in Osteoporosis 10/21/2013 10:03:17 AM
GenKyoTex S.A. Receives FDA IND Approval for Phase II Clinical Study With First in Class NOX Inhibitor GKT137831 9/9/2013 10:22:40 AM
GenKyoTex S.A. 's First in Class NOX Inhibitor GKT137831 to be Presented at Kidney Week 2012 10/15/2012 10:18:39 AM
GenKyoTex S.A. s Lead NOX Inhibitor GKT137831 Demonstrates Activity in Models of Liver Fibrosis 8/8/2012 10:21:51 AM
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug 7/9/2012 7:18:28 AM
GenKyoTex S.A. Announces Successful Phase Ia Data with First in Class NOX Inhibitor GKT137831 6/22/2012 10:14:44 AM
12
//-->